Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Topic: Clinical Management of HCC – State of the Art in 2021

A special issue of Hepatoma Research

ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)

Submission deadline: 15 Jul 2021

Guest Editor(s)

  • Jörg Schlaak, MD
    Director, Department of Internal medicine, Evangelisches Klinikum Niederrhein GmbH, Duisburg, Germany.

    Website | E-mail

Special Issue Introduction

Hepatocellular carcinoma (HCC) is still the most common primary liver malignancy. HCC incidence has doubled, and mortality rates have increased in recent decades despite efforts for prevention and screening as well as the development of new technologies for diagnosis and treatment. More recently, the coronavirus pandemic has attracted worldwide attention while, somehow, other clinical subjects appear to have been out of focus. Nevertheless, constant progress has been made in the field of HCC, which has prompted us to encourage the leading experts to sum up the state of the art in the management of this tumour in 2021 at the beginning of the post coronavirus era. The following topics are to be covered:

1.Prevention of HCC and surveillance of high risk patients
2.Histopathology – when and what
3.Molecular diagnostics
4.Radiological imaging
5.Evaluation of liver function before and during therapy
6.To resect or not to resect
7.Liver transplantation – still a good idea?
8.Interventional therapies
10.Old and new drugs for HCC


1. Ali Canbay  Department of Medicine, Universitätsklinikum Knappschaftskrankenhaus Bochum, Ruhr-Universität Bochum, Bochum, Germany.
2. Andrea Tannapfel  Institute for Pathology, Ruhr University Bochum, Bochum, Germany.
3. Guido Guenther Heinrich Gerken  Department of Gastroenterology and Hepatology, University of Essen, Essen, Germany.
4. Martin Karl Walz  Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
5. Yasunori Minami  Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
6. Michael A. Heneghan  Institute of Liver Studies, King's College Hospital, London, SE5 9RS, UK.
7. Hikmet Akkiz  Çukurova University, Adana, Turkey.
8. Beatrice L. Madrazo  Department of Radiology, University of Miami/Miller School of Medicine, Miami, FL, USA.
9. Elisa Callegari  Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Italy.
The list is arranged in no particular order and being updated.

Submission Deadline

15 Jul 2021

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 15 Jul 2021
Contacts: Victoria Lee, Assistant Editor,

Published Articles

© 2016-2022 OAE Publishing Inc., except certain content provided by third parties